Pinosylvin reduced migration and invasion of oral cancer carcinoma by regulating matrix metalloproteinase-2 expression and extracellular signal-regulated kinase pathway

Biomed Pharmacother. 2019 Sep:117:109160. doi: 10.1016/j.biopha.2019.109160. Epub 2019 Jul 1.

Abstract

Background: Pinosylvin possesses several biological properties, including anti-inflammatory, antitumor, and antioxidant characteristics. However, the effects of pinosylvin on the migration and invasion of human oral cancer cells and the underlying mechanisms remain unclear.

Hypothesis/purpose: In this research, we investigated the outcome of different concentrations of pinosylvin (0-80 μM) on the metastatic and invasive abilities of SAS, SCC-9, and HSC-3 cells.

Methods and results: Western blotting assay and Gelatin zymography assay indicated that pinosylvin inhibited the enzymatic activity of matrix metalloproteinase-2 (MMP-2) and reduced its protein level but increased the expression of tissue inhibitor of metalloproteinase-2 (TIMP-2). Additionally, the wound healing assay and Transwell method showed that pinosylvin reduced the migration of SAS, SCC-9 and HSC-3 oral cancer cells. Besides, pinosylvin decreased the phosphorylation of ERK1/2 protein experssion in both SAS and SCC-9 cells.

Conclusion: These results indicate that pinosylvin is a potential anticancer agent for preventing oral cancer metastasis.

Keywords: MMP-2; Migration; Oral squamous cell carcinoma; Pinosylvin; TIMP-2.

MeSH terms

  • Carcinoma, Squamous Cell / drug therapy*
  • Carcinoma, Squamous Cell / metabolism
  • Cell Line, Tumor
  • Cell Movement / drug effects*
  • Extracellular Signal-Regulated MAP Kinases / metabolism*
  • Humans
  • MAP Kinase Signaling System / drug effects
  • Matrix Metalloproteinase 2 / metabolism*
  • Matrix Metalloproteinase Inhibitors / pharmacology
  • Mouth Neoplasms / drug therapy*
  • Mouth Neoplasms / metabolism
  • Neoplasm Invasiveness / pathology*
  • Phosphorylation / drug effects
  • Signal Transduction / drug effects
  • Stilbenes / pharmacology*
  • Tissue Inhibitor of Metalloproteinase-2 / metabolism

Substances

  • Matrix Metalloproteinase Inhibitors
  • Stilbenes
  • Tissue Inhibitor of Metalloproteinase-2
  • pinosylvin
  • Extracellular Signal-Regulated MAP Kinases
  • Matrix Metalloproteinase 2